No headlines found.
No press releases found.
No news found.
Liminatus Pharma - Warrants trades on the stock market under the symbol LIMNW.
As of March 13, 2026, LIMNW stock price was flat at $0.06 with 140 million shares trading.
LIMNW has a beta of 3.62, meaning it tends to be more sensitive to market movements. LIMNW has a correlation of 0.02 to the broad based SPY ETF.
LIMNW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
LIMNW support price is $.04 and resistance is $.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIMNW shares will trade within this expected range on the day.
